ArticleAdvances in radiation oncology2026
Nonprostate Cancer Deaths Best Predict Long-Term Survival in Men Aged ≤59 Years Treated With Low Dose Rate Brachytherapy With or Without Supplemental Therapies: A Mandate for Health Enhancement.
Peter Orio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.